Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
Get Insiders for : 
Gilead Sciences Inc (GILD)  
$65.51 0.31 (0.48%) as of 4:30 Wed 5/1


Download
   
Exchange: Nasdaq National Market
Security Type: Common
Shares Out: 1,250,000,000
Market Cap: 81.89(B)
Last Volume: 7,231,910 Avg Vol: 8,754,576
52 Week Range: $65.27 - $87.29
Level I Sector: Health Care
Level II Sector: Drugs
Level III Sector: Biotechnology

Member Indexes:
    S&P COMPOSITE 1500     NASDAQ BIOTECHNOLOGY
    NASDAQ COMPOSITE     NASDAQ-100
    S&P 500     NASDAQ NNM COMPOSITE

Rankings:
     
Insider 3 Months    :   -
Insider 6 Months    :   -
Insider 3/6 Months :   -
Guru Rank Number :  259
Guru Rank Value     : 4.6
Guru Occurances    : 2

 

            6 Months   1 Year   2 Year  
 
Company Profile   Gilead Sciences is a research-based biopharmaceutical company that discovers, develops and commercializes medicines. Co.'s primary areas of focus include viral diseases, inflammatory diseases and oncology. Co.'s products include: Biktarvy® for the treatment of HIV-1 infection in certain patients; Veklury® (remdesivir), for the treatment of Coronavirus Disease 2019 requiring hospitalization; Epclusa® for the treatment of chronic hepatitis C virus infection; Vemlidy® for the treatment of chronic hepatitis B virus infection in adults with compensated liver disease; Yescarta® (axicabtagene ciloleucel) for the treatment of adult patients with relapsed or refractory large B-cell lymphoma.

 
 
Summary  (Direct Transactions Only) 3 Months 6 Months 12 Months 24 Months
Total Shares Bought 0 0 0 0
Total Buy Value $0 $0 $0 $0
Total People Bought 0 0 0 0
Total Buy Transactions 0 0 0 0
Total Shares Sold 12,230 25,472 38,458 80,792
Total Sell Value $890,904 $2,022,270 $3,052,046 $6,445,296
Total People Sold 1 3 3 4
Total Sell Transactions 3 5 9 14
End Date 2024-02-01 2023-10-31 2023-05-02 2022-05-02

   
Records found: 2493
  Page 8 of 100  
Filer's Name Relation Title Off-Dir-10% Tran. Date Form Action Price Mkt Value D/I Shares Holdings
Rank

  
3m +/-  
Form
   Pletcher Brett A EVP,Corp Affairs & Gen Counsel   •       •      –    2022-03-10 4 D $57.92 $120,995 D/D (2,089) 36,210     -
   Pletcher Brett A EVP,Corp Affairs & Gen Counsel   •       •      –    2022-03-10 4 OE $0.00 $0 D/D 5,723 38,299     -
   Parsey Merdad Chief Medical Officer   •       •      –    2022-03-10 4 D $57.92 $203,010 D/D (3,505) 41,265     -
   Parsey Merdad Chief Medical Officer   •       •      –    2022-03-10 4 OE $0.00 $0 D/D 7,612 44,770     -
   Mercier Johanna Chief Commercial Officer   •       •      –    2022-03-10 4 D $57.92 $186,560 D/D (3,221) 34,544     -
   Mercier Johanna Chief Commercial Officer   •       •      –    2022-03-10 4 OE $0.00 $0 D/D 6,987 37,765     -
   Oday Daniel Patrick Chairman & CEO   •       •      –    2022-03-10 4 D $57.92 $640,132 D/D (11,052) 249,344     -
   Oday Daniel Patrick Chairman & CEO   •       •      –    2022-03-10 4 OE $0.00 $0 D/D 24,003 260,396     -
   Oday Daniel Patrick Chairman & CEO   •       •      –    2022-03-01 4 D $60.26 $1,400,744 D/D (23,245) 236,393     -
   Oday Daniel Patrick Chairman & CEO   •       •      –    2022-03-01 4 OE $0.00 $0 D/D 54,284 259,638     -
   Pletcher Brett A EVP,Corp Affairs & Gen Counsel   •       •      –    2022-02-15 4 A $52.13 $18,141 D/D 348 32,924     -
   Parsey Merdad Chief Medical Officer   •       •      –    2022-02-15 4 A $52.13 $18,141 D/D 348 41,613     -
   Dickinson Andrew D Chief Financial Officer   •       •      –    2022-02-15 4 A $52.13 $18,141 D/D 348 64,353     -
   Pletcher Brett A EVP,Corp Affairs & Gen Counsel   •       •      –    2022-02-09 4 AS $63.89 $108,038 D/D (1,691) 32,576 -5%     
   Wilfong Diane E SVP, Controller & CAO   •       •      –    2022-02-06 4 D $63.90 $33,228 D/D (520) 24,219     -
   Wilfong Diane E SVP, Controller & CAO   •       •      –    2022-02-06 4 OE $0.00 $0 D/D 1,864 24,739     -
   Pletcher Brett A EVP,Corp Affairs & Gen Counsel   •       •      –    2022-02-06 4 D $63.90 $66,200 D/D (1,036) 34,267     -
   Pletcher Brett A EVP,Corp Affairs & Gen Counsel   •       •      –    2022-02-06 4 OE $0.00 $0 D/D 2,727 35,303     -
   Dickinson Andrew D Chief Financial Officer   •       •      –    2022-02-06 4 D $63.90 $49,011 D/D (767) 59,706     -
   Dickinson Andrew D Chief Financial Officer   •       •      –    2022-02-06 4 OE $0.00 $0 D/D 1,817 60,473     -
   Pletcher Brett A EVP,Corp Affairs & Gen Counsel   •       •      –    2022-02-01 4 AS $68.54 $963,682 D/D (14,061) 32,576 -11%     
   Mercier Johanna Chief Commercial Officer   •       •      –    2022-01-26 4 A $0.00 $0 D/D 18,630 30,778     -
   Pletcher Brett A EVP,Corp Affairs & Gen Counsel   •       •      –    2022-01-26 4 D $67.34 $382,559 D/D (5,681) 46,637     -
   Pletcher Brett A EVP,Corp Affairs & Gen Counsel   •       •      –    2022-01-26 4 A $0.00 $0 D/D 35,004 52,318     -
   Oday Daniel Patrick Chairman & CEO   •       •      –    2022-01-26 4 D $67.34 $2,278,314 D/D (33,833) 205,354     -
  2493 Records found
  1  2  3  4  5  6  7  8  9  Next   
  Page 8 of 100
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
  OE - Options Exercised A - Acquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us